Skin care remains a necessity even as consumers spend more time at home. But what will they want, and how will the market fare, after the coronavirus pandemic?
Sales of cannabidiol-based products have soared during the past year, and now formulators are rolling out CBD products designed to ease a variety of ailments.
Two types of cannabinoid receptors have been identified in human cells. Keratinocytes contain both, justifying interest in CBD among cosmetic companies.
By Paolo U Giacomoni, PhD, Insight Analysis Consulting 04.10.20
Dermatologist Vivian Y. Shi provides insight into this chronic condition, if ingredients like CBD hold promise and what skin care brands can do to help.